CLINICAL TRIALS PROFILE FOR TRIOSTAT
✉ Email this page to a colleague
All Clinical Trials for TRIOSTAT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00027417 ↗ | Study of Triostat in Infants During Heart Surgery | Completed | Michael Portman | Phase 3 | 2001-04-01 | This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery. |
NCT02320669 ↗ | Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass | Unknown status | Seattle Children's Hospital | Phase 3 | 2014-11-01 | This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery. Funding Source - FDA OOPD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRIOSTAT
Condition Name
Clinical Trial Locations for TRIOSTAT
Trials by Country
Clinical Trial Progress for TRIOSTAT
Clinical Trial Phase
Clinical Trial Sponsors for TRIOSTAT
Sponsor Name